PMC:7079563 / 22597-24948
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
703 | 531-540 | Species | denotes | 2019-nCoV | Tax:2697049 |
704 | 629-638 | Species | denotes | 2019-nCoV | Tax:2697049 |
705 | 740-749 | Species | denotes | 2019-nCoV | Tax:2697049 |
706 | 1114-1120 | Species | denotes | People | Tax:9606 |
707 | 1142-1150 | Species | denotes | Patients | Tax:9606 |
708 | 1642-1651 | Species | denotes | 2019-nCoV | Tax:2697049 |
709 | 1789-1794 | Species | denotes | human | Tax:9606 |
710 | 1795-1803 | Species | denotes | patients | Tax:9606 |
711 | 1948-1956 | Species | denotes | MERS-CoV | Tax:1335626 |
712 | 1984-1989 | Species | denotes | mouse | Tax:10090 |
713 | 1998-2003 | Species | denotes | human | Tax:9606 |
714 | 2304-2312 | Species | denotes | patients | Tax:9606 |
715 | 941-950 | Chemical | denotes | lopinavir | MESH:D061466 |
716 | 1203-1212 | Chemical | denotes | ribavirin | MESH:D012254 |
717 | 1226-1245 | Chemical | denotes | lopinavir-ritonavir | MESH:C558899 |
718 | 1680-1690 | Chemical | denotes | remdesivir | MESH:C000606551 |
719 | 1833-1843 | Chemical | denotes | Remdesivir | MESH:C000606551 |
720 | 2036-2046 | Chemical | denotes | remdesivir | MESH:C000606551 |
721 | 75-97 | Disease | denotes | coronavirus infections | MESH:D018352 |
722 | 1063-1072 | Disease | denotes | pneumonia | MESH:D011014 |
723 | 1624-1633 | Disease | denotes | infection | MESH:D007239 |
724 | 1736-1755 | Disease | denotes | 2019-nCoV infection | MESH:C000657245 |
725 | 1809-1826 | Disease | denotes | 2019-nCoV disease | MESH:C000657245 |
726 | 2074-2089 | Disease | denotes | virus infection | MESH:D001102 |
727 | 2162-2182 | Disease | denotes | 2019-nCoV infections | MESH:C000657245 |
728 | 2215-2224 | Disease | denotes | infection | MESH:D007239 |
729 | 2289-2303 | Disease | denotes | critically ill | MESH:D016638 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T39 | 791-794 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T40 | 1920-1923 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T41 | 1970-1975 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T42 | 2344-2350 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T20 | 451-456 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T77 | 87-97 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T78 | 845-849 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T79 | 1063-1072 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T80 | 1156-1160 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T81 | 1497-1499 | Disease | denotes | GS | http://purl.obolibrary.org/obo/MONDO_0005773 |
T82 | 1624-1633 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T83 | 1736-1755 | Disease | denotes | 2019-nCoV infection | http://purl.obolibrary.org/obo/MONDO_0100096 |
T84 | 1746-1755 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T85 | 1943-1947 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T86 | 2068-2073 | Disease | denotes | Ebola | http://purl.obolibrary.org/obo/MONDO_0005737 |
T87 | 2074-2089 | Disease | denotes | virus infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T88 | 2080-2089 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T89 | 2162-2182 | Disease | denotes | 2019-nCoV infections | http://purl.obolibrary.org/obo/MONDO_0100096 |
T90 | 2215-2224 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T164 | 69-74 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T165 | 143-144 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T166 | 254-255 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T167 | 283-284 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T168 | 428-429 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T169 | 510-518 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T170 | 588-591 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T171 | 612-620 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T172 | 721-731 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T173 | 980-982 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
T174 | 1608-1613 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T175 | 1789-1794 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T176 | 1828-1830 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
T177 | 1844-1847 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T178 | 1876-1877 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T179 | 1924-1931 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T180 | 1961-1975 | http://purl.obolibrary.org/obo/CL_0000010 | denotes | cultured cells |
T181 | 1984-1989 | http://purl.obolibrary.org/obo/CLO_0007836 | denotes | mouse |
T182 | 1998-2003 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T183 | 2004-2011 | http://purl.obolibrary.org/obo/NCBITaxon_9443 | denotes | primate |
T184 | 2074-2079 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T185 | 2249-2252 | http://purl.obolibrary.org/obo/CL_0000784 | denotes | IPC |
T186 | 2344-2350 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T38 | 32-41 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T39 | 245-250 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T40 | 344-348 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T41 | 479-484 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T42 | 551-555 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T43 | 577-587 | Chemical | denotes | nelfinavir | http://purl.obolibrary.org/obo/CHEBI_7496 |
T44 | 602-611 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T45 | 653-665 | Chemical | denotes | pitavastatin | http://purl.obolibrary.org/obo/CHEBI_32020 |
T46 | 667-677 | Chemical | denotes | perampanel | http://purl.obolibrary.org/obo/CHEBI_71013 |
T47 | 683-695 | Chemical | denotes | praziquantel | http://purl.obolibrary.org/obo/CHEBI_45267 |
T48 | 795-799 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T49 | 806-813 | Chemical | denotes | Kaletra | http://purl.obolibrary.org/obo/CHEBI_145924 |
T50 | 885-904 | Chemical | denotes | protease inhibitors | http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258 |
T52 | 894-904 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T53 | 906-915 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T54 | 941-950 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T55 | 1019-1026 | Chemical | denotes | Kaletra | http://purl.obolibrary.org/obo/CHEBI_145924 |
T56 | 1187-1192 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T57 | 1203-1212 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
T58 | 1214-1224 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
T59 | 1226-1245 | Chemical | denotes | lopinavir-ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
T60 | 1226-1235 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T61 | 1236-1245 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T62 | 1251-1266 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T63 | 1296-1301 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T64 | 1332-1347 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
T65 | 1332-1341 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T66 | 1342-1347 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T67 | 1354-1357 | Chemical | denotes | FAD | http://purl.obolibrary.org/obo/CHEBI_16238|http://purl.obolibrary.org/obo/CHEBI_57692|http://purl.obolibrary.org/obo/CHEBI_73627 |
T70 | 1367-1372 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T71 | 1383-1392 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
T72 | 1394-1405 | Chemical | denotes | penciclovir | http://purl.obolibrary.org/obo/CHEBI_7956 |
T73 | 1430-1441 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T74 | 1470-1485 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
T75 | 1470-1479 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T76 | 1480-1485 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T77 | 1497-1504 | Chemical | denotes | GS-5734 | http://purl.obolibrary.org/obo/CHEBI_145994 |
T78 | 1497-1499 | Chemical | denotes | GS | http://purl.obolibrary.org/obo/CHEBI_73516 |
T79 | 1519-1524 | Chemical | denotes | T-705 | http://purl.obolibrary.org/obo/CHEBI_134722 |
T80 | 1680-1690 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T81 | 1695-1706 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T82 | 1888-1902 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
T83 | 1888-1897 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T84 | 1898-1902 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T85 | 2036-2046 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T86 | 2249-2252 | Chemical | denotes | IPC | http://purl.obolibrary.org/obo/CHEBI_53004 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T172 | 0-98 | Sentence | denotes | There are currently no approved antiviral treatments or vaccines for human coronavirus infections. |
T173 | 99-274 | Sentence | denotes | The development of safe, stable vaccines is a huge challenge and vaccines would ideally be broad-spectrum, so the research and development of new drugs is a very long process. |
T174 | 275-391 | Sentence | denotes | In such a sudden epidemic, scientists were not able to carry out new drug development by the traditional principles. |
T175 | 392-541 | Sentence | denotes | Therefore, there is another option: a systematic and large-scale screening of existing drugs to see whether they have activity against the 2019-nCoV. |
T176 | 542-639 | Sentence | denotes | Recently drug screening found that nelfinavir has potential antiviral activity against 2019-nCoV. |
T177 | 640-755 | Sentence | denotes | In addition, pitavastatin, perampanel, and praziquantel might also have moderate activities against 2019-nCoV [39]. |
T178 | 756-922 | Sentence | denotes | Based on previous studies, an anti-HIV drug named Kaletra may have therapeutic effect on SARS and MERS, which is composed of two protease inhibitors, ritonavir (CAS#: |
T179 | 923-957 | Sentence | denotes | 155,213-67-5) and lopinavir (CAS#: |
T180 | 958-1003 | Sentence | denotes | 192,725-17-0) [[40], [41], [42], [43], [44]]. |
T181 | 1004-1141 | Sentence | denotes | More recently, Kaletra was also recommended to treat Wuhan pneumonia by the National Health Commission of the People’s Republic of China. |
T182 | 1142-1325 | Sentence | denotes | Patients with SARS or MERS have used several drugs including ribavirin, interferon, lopinavir-ritonavir, and corticosteroids, but the efficacy of certain drugs is still controversial. |
T183 | 1326-1652 | Sentence | denotes | Other antiviral drugs, like FAD-approved drugs including ribavirin, penciclovir, nitrazine, nalfamusta, chloroquine, and the two broad-spectrum antiviral drugs redexivir (GS-5734) and favivir (T-705), are being evaluated by measuring the effects of these compounds on cytotoxicity, virus yield and infection rate of 2019-nCoV. |
T184 | 1653-1832 | Sentence | denotes | Recent results showed that remdesivir and chloroquine are effective in controlling 2019-nCoV infection in vitro and may be evaluated in human patients with 2019-nCoV disease [45]. |
T185 | 1833-2025 | Sentence | denotes | Remdesivir has recently been recognized as a promising antiviral drug against multiple RNA viruses (including SARS/MERS-CoV) in cultured cells, and in mouse and non-human primate (NHP) models. |
T186 | 2026-2114 | Sentence | denotes | Currently remdesivir for the treatment of Ebola virus infection is in clinical research. |
T187 | 2115-2183 | Sentence | denotes | It is promising that these compounds can treat 2019-nCoV infections. |
T188 | 2184-2351 | Sentence | denotes | Moreover, the fifth edition of infection prevention and control (IPC) guidance announced that severe and critically ill patients could be treated with recovery plasma. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T27 | 1063-1072 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32087334-17597972-69695019 | 974-976 | 17597972 | denotes | 40 |
32087334-14985565-69695020 | 980-982 | 14985565 | denotes | 41 |
32087334-18706430-69695021 | 986-988 | 18706430 | denotes | 42 |
32087334-26483999-69695022 | 992-994 | 26483999 | denotes | 43 |
32087334-29382391-69695023 | 998-1000 | 29382391 | denotes | 44 |